NIH documents say the policy doesn’t end the use of “cell lines” created years ago from fetal cells. Those are cloned copies of cells, such as embryonic stem cells, adapted to grow continuously in labs. Bhattacharya’s statement said NIH will soon seek comment about potential ways “to reduce or potentially replace reliance on human embryonic stem cells.”
[You must be logged in to view images. Log in or Register.]
01-22-2026, 11:53 PM
Threaded Mode